Invus Global Management, LLC - 29 Aug 2025 SCHEDULE 13G Report for vTv Therapeutics Inc. Class A Common Stock, $0.01 par value per share (VTVT)

Filing Manager
Invus Global Management, LLC
Reporting Manager
Raymond Debbane
Security
vTv Therapeutics Inc. Class A Common Stock, $0.01 par value per share
Symbol
VTVT
Shares outstanding
3.48M shares
Disclosed Ownership
348K shares
Ownership
9.99%
Form type
SCHEDULE 13G
Filing time
08 Sep 2025, 17:43:43 UTC
Date of event
29 Aug 2025
Next filing
12 Nov 2025
SEC
View on sec.gov

Reporting Managers (8)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Invus Public Equities, L.P. 8.8% 306K 306K 0 /s/ Raymond Debbane Raymond Debbane, President of Invus Public Equities Advisors, LLC, its general partner
Invus Public Equities Advisors, LLC 8.8% 306K 306K 0 /s/ Raymond Debbane Raymond Debbane, President
Invus Global Management, LLC 8.8% 306K 306K 0 /s/ Raymond Debbane Raymond Debbane, President
Siren, L.L.C. 8.8% 306K 306K 0 /s/ Raymond Debbane Raymond Debbane, President
Avicenna Life Sci Master Fund LP 1.3% 41.8K 41.8K 0 /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer of Avicenna Life Sci Master GP LLC, its general partner
Avicenna Life Sci Master GP LLC 1.3% 41.8K 41.8K 0 /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer
Ulys, L.L.C. 1.3% 41.8K 41.8K 0 /s/ Raymond Debbane Raymond Debbane, President
Raymond Debbane 9.99% 348K 348K 0 /s/ Raymond Debbane Raymond Debbane